The largest database of trusted experimental protocols

3 protocols using granzyme b clone gb12

1

Lung dissociation and immune cell analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The left lung lobe was excised post BAL, crudely dissociated using the GentleMACS™ tissue dissociator (Miltenyi Biotech, Germany) and digested upon incubation at 37°C in buffer containing 1 mg/mL collagenase Type XI and 80 units/mL Bovine Pancreatic DNase Type IV (both Sigma-Aldrich, Dorset, UK). For intracellular cytokine staining (ICS) cells were stimulated with PMA (50 ng/mL) and ionomycin (500 ng/mL) with BD GolgiStop™ (BD Biosciences) for 3 h at 37°C. Lung and BAL cells were incubated with anti-mouse CD16/CD32 (FC Block, BD Biosciences) prior to staining for cell surface markers: CD3e (clone 500A2), CD4 (clone RM4-5), CD8a (clone 53-6.7), NK1.1 (clone PK136), NKp46 (clone 29A1.4) and CD69 (clone H1.2F3) (all BD Biosciences). Cells were washed and stained with Live/Dead fixable dead cell stain kit (Invitrogen), followed by incubation with BD Fix/Perm solution (BD Biosciences). For ICS, cells were stained for IFN-γ (clone XMG1.2, BD Biosciences) and granzyme B (clone GB12, Invitrogen) in BD PermWash™ (BD Biosciences). Data were acquired using a BD LSR II digital flow cytometer (BD Biosciences) and BD FACS Diva software. Analysis was performed using FlowJo 9.3.1.2 software.
+ Open protocol
+ Expand
2

Quantifying CD107a and Granzyme B in CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell degranulation was determined by CD107a and intracellular granzyme B staining. Briefly, CD4+ T cells were co-cultured with target cells at a 10:1 ratio. 5μL APC-CD107a (clone H4A3, BD Biosciences) antibody was added at the beginning of culture. After 1 hour, monensin and Brefeldin A (Thermo Fisher Scientific) were added according to manufacturer’s instructions to block intracellular protein transport and cells were incubated for another 5 hours. Cells were collected, surface stained, and fixed and permeabilized in Cytofix/Cytoperm solution (BD Biosciences) for 30 minutes. Cells were then intracellular stained for granzyme B (clone GB12, Invitrogen) in permeabilization buffer and analyzed by a flow cytometer. For blocking experiments, 10μg/mL recombinant anti-HLA-E (Thermo Fisher Scientific), anti-CD48 (Thermo Fisher Scientific), or isotype antibody was added to target cells for 30 minutes at 37°C prior to co-culture and additionally during the 6-hour co-culture.
+ Open protocol
+ Expand
3

Lung dissociation and immune cell analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The left lung lobe was excised post BAL, crudely dissociated using the GentleMACS™ tissue dissociator (Miltenyi Biotech, Germany) and digested upon incubation at 37°C in buffer containing 1 mg/mL collagenase Type XI and 80 units/mL Bovine Pancreatic DNase Type IV (both Sigma-Aldrich, Dorset, UK). For intracellular cytokine staining (ICS) cells were stimulated with PMA (50 ng/mL) and ionomycin (500 ng/mL) with BD GolgiStop™ (BD Biosciences) for 3 h at 37°C. Lung and BAL cells were incubated with anti-mouse CD16/CD32 (FC Block, BD Biosciences) prior to staining for cell surface markers: CD3e (clone 500A2), CD4 (clone RM4-5), CD8a (clone 53-6.7), NK1.1 (clone PK136), NKp46 (clone 29A1.4) and CD69 (clone H1.2F3) (all BD Biosciences). Cells were washed and stained with Live/Dead fixable dead cell stain kit (Invitrogen), followed by incubation with BD Fix/Perm solution (BD Biosciences). For ICS, cells were stained for IFN-γ (clone XMG1.2, BD Biosciences) and granzyme B (clone GB12, Invitrogen) in BD PermWash™ (BD Biosciences). Data were acquired using a BD LSR II digital flow cytometer (BD Biosciences) and BD FACS Diva software. Analysis was performed using FlowJo 9.3.1.2 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!